» Articles » PMID: 30097961

RNA MA Modification and Its Function in Diseases

Overview
Journal Front Med
Specialty General Medicine
Date 2018 Aug 12
PMID 30097961
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

N-methyladenosine (mA) is the most common post-transcriptional RNA modification throughout the transcriptome, affecting fundamental aspects of RNA metabolism. mA modification could be installed by mA "writers" composed of core catalytic components (METTL3/METTL14/WTAP) and newly defined regulators and removed by mA "erasers" (FTO and ALKBH5). The function of mA is executed by mA "readers" that bind to mA directly (YTH domain-containing proteins, eIF3 and IGF2BPs) or indirectly (HNRNPA2B1). In the past few years, advances in mA modulators ("writers," "erasers," and "readers") have remarkably renewed our understanding of the function and regulation of mA in different cells under normal or disease conditions. However, the mechanism and the regulatory network of mA are still largely unknown. Moreover, investigations of the mA physiological roles in human diseases are limited. In this review, we summarize the recent advances in mA research and highlight the functional relevance and importance of mA modification in in vitro cell lines, in physiological contexts, and in cancers.

Citing Articles

The METTL3/m6A Reader Protein YTHDF1 Regulates Endothelial Cell Pyroptosis by Enhancing NLRP3 Expression to Affect Soft Tissue Injury.

Xie X, Fang F J Inflamm Res. 2024; 17:11331-11346.

PMID: 39722730 PMC: 11669061. DOI: 10.2147/JIR.S479276.


Multimodal tumor suppression by METTL3 gene knockdown in melanoma and colon cancer cells.

Bazargani A, Taha M, Mohammad Soltani B, Javeri A Histochem Cell Biol. 2024; 163(1):21.

PMID: 39720980 DOI: 10.1007/s00418-024-02346-1.


A review of current developments in RNA modifications in lung cancer.

Zhang S, Liu Y, Liu K, Hu X, Gu X Cancer Cell Int. 2024; 24(1):347.

PMID: 39456034 PMC: 11515118. DOI: 10.1186/s12935-024-03528-6.


Methyltransferase-Like 3-Mediated N6-Methyladenosine RNA Methylation Regulates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Pyroptosis by Targeting PTEN.

Jiang Y, Liu H, Shi R, Hao Y, Zhang J, Xin W J Am Heart Assoc. 2024; 13(19):e034470.

PMID: 39344585 PMC: 11681462. DOI: 10.1161/JAHA.124.034470.


m6A methylation in myocardial tissue of septic mice analyzed using MeRIP/m6A-sequencing and RNA-sequencing.

Liang X, Hu X, Li J, Zhang B, Gu T, Wang H Funct Integr Genomics. 2024; 24(5):173.

PMID: 39320434 DOI: 10.1007/s10142-024-01452-6.


References
1.
Wang X, Zhao B, Roundtree I, Lu Z, Han D, Ma H . N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell. 2015; 161(6):1388-99. PMC: 4825696. DOI: 10.1016/j.cell.2015.05.014. View

2.
Liu N, Pan T . Probing RNA Modification Status at Single-Nucleotide Resolution in Total RNA. Methods Enzymol. 2015; 560:149-59. DOI: 10.1016/bs.mie.2015.03.005. View

3.
Luo S, Tong L . Molecular basis for the recognition of methylated adenines in RNA by the eukaryotic YTH domain. Proc Natl Acad Sci U S A. 2014; 111(38):13834-9. PMC: 4183320. DOI: 10.1073/pnas.1412742111. View

4.
Munns T, Sims H . Methylation and processing of transfer ribonucleic acid in mammalian and bacterial cells. J Biol Chem. 1975; 250(6):2143-9. View

5.
Slobodin B, Han R, Calderone V, Vrielink J, Loayza-Puch F, Elkon R . Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation. Cell. 2017; 169(2):326-337.e12. PMC: 5388891. DOI: 10.1016/j.cell.2017.03.031. View